Electron beam welding machine market is projected to grow from $33.5 million in 2026 and is projected to reach $53.8 million by 2035, growing at a CAGR of 8.6% during the forecast period 2026-2035. The Indian electron beam welding machine market is witnessing steady growth due to increasing demand for high-precision welding technologies across aerospace, defence, energy, and heavy engineering industries. Electron beam welding machines are increasingly being adopted for applications requiring deep penetration welding, minimal distortion, and high structural integrity in critical components. Growing domestic manufacturing activities under industrial modernisation initiatives and increasing localisation of aerospace and defence production are supporting the deployment of advanced welding systems across the country. Manufacturers are also focusing on improving automation capabilities and integrating CNC-enabled control systems to enhance production efficiency and welding accuracy.

The volume booster software market was valued at $1.1 billion in 2025 and is projected to reach $3.3 billion by 2035, growing at a CAGR of 11.1% during the forecast period (2026–2035). The increasing penetration of smart devices, rising digital media consumption, and growing demand for enhanced audio experiences are significantly driving the adoption of volume booster software globally. As users increasingly rely on smartphones, laptops, and entertainment systems for streaming music, video content, and communication, the need for improved sound clarity and amplification beyond default hardware limitations is accelerating market growth.

Urothelial cancer treatment market was valued at $5.1 billion in 2025 and is projected to reach $14.8 billion by 2035, growing at a CAGR of 11.3% during the forecast period (2026–2035). The increasing global burden of cancer, alongside rising adoption of advanced oncology therapies, is significantly driving demand for urothelial cancer treatments. Governments and healthcare systems are strengthening cancer control programs, improving early diagnosis rates, and expanding access to innovative therapies, thereby accelerating market growth. The shift toward precision medicine and immunotherapy is further transforming treatment paradigms, improving patient survival outcomes, and fueling investment across pharmaceutical pipelines.

Substance abuse treatment market was valued at $16.03 billion in 2025 and is projected to reach $38.86 billion by 2035, growing at a CAGR of 9.2% during the forecast period (2026–2035). The rising global burden of substance use disorders, combined with increasing government intervention and expanding access to treatment services, is significantly driving market growth. Governments across major economies are strengthening public health frameworks to address opioid, alcohol, and nicotine dependence through structured treatment programs, reimbursement expansion, and awareness campaigns. Treatment approaches such as medication-assisted treatment (MAT), behavioral therapy, and counseling programs are gaining strong traction due to their effectiveness in improving recovery outcomes and reducing relapse rates.

Sortation system market is witnessing strong expansion and is projected to grow from $6.1 billion in 2025 to $11.1 billion by 2035, registering a CAGR of 6.2% during the forecast period. Growth is primarily driven by rapid expansion in global e-commerce logistics, rising warehouse automation investments, and increasing demand for high-speed parcel processing systems across industries. A major macro driver supporting this growth is the explosive rise in global parcel and express delivery volumes. According to the Universal Postal Union (UPU), global postal parcel volumes have increased significantly in recent years due to cross-border e-commerce expansion. Additionally, the International Trade Centre (ITC Trade Map) highlights continuous growth in global merchandise trade, which is directly increasing the need for automated sorting infrastructure in logistics hubs and fulfilment centres. Increasing adoption of automation in logistics is further accelerating market demand. 

Skeletal dysplasia market was valued at $1.5 billion in 2025 and is projected to reach $4.1 billion by 2035, growing at a CAGR of 10.6% during the forecast period (2026–2035). The market growth is primarily driven by the increasing prevalence of rare genetic disorders and the rising advancements in targeted therapies. Government-backed rare disease initiatives and orphan drug incentives are significantly accelerating research, diagnosis, and treatment accessibility. Skeletal dysplasia, comprising over 450 distinct genetic conditions affecting bone and cartilage development, is witnessing heightened clinical attention due to improved genetic screening and early diagnosis capabilities.

Scleroderma therapeutics market was valued at $2.6 billion in 2025 and is projected to reach $4.4 billion by 2035, growing at a CAGR of 5.2% during the forecast period (2026–2035). The increasing prevalence of autoimmune diseases and the rising burden of rare chronic disorders are significantly driving demand for advanced therapeutic solutions in the market. Government-backed rare disease initiatives and improved diagnostic capabilities are contributing to early detection and treatment adoption. Scleroderma, a complex autoimmune condition characterized by fibrosis and vascular abnormalities, requires long-term management through targeted pharmacological interventions, thereby strengthening sustained demand across treatment segments.

Restless legs syndrome market is projected to grow from $1.4 billion in 2025 to $2.5 billion by 2035, expanding at a CAGR of 6.1% during the forecast period. The market growth is primarily driven by increasing prevalence of neurological and sleep-related disorders, rising awareness regarding Restless Legs Syndrome (RLS), and growing adoption of advanced pharmacological therapies for symptom management and sleep improvement. A key macro driver influencing the market is the growing global burden of sleep disorders and neurological conditions. According to the World Health Organization (WHO) and National Institutes of Health (NIH), sleep disorders and chronic neurological diseases are increasing significantly due to ageing populations, lifestyle changes, stress, and chronic health conditions such as Parkinson’s disease, diabetes, kidney disorders, and iron deficiency anaemia, all of which are closely associated with Restless Legs Syndrome. Additionally, increasing awareness regarding the impact of sleep disorders on mental health, productivity, and quality of life is encouraging higher diagnosis and treatment rates globally.

Recycled glass market is projected to grow from $6.7 billion in 2025 to $11.8 billion by 2035, expanding at a CAGR of 5.8% during the forecast period. The market growth is primarily driven by increasing focus on circular economy practices, rising demand for sustainable construction materials, and growing adoption of recycled content in glass packaging manufacturing. A key macro driver influencing the market is the rising global emphasis on waste reduction and resource efficiency. According to the United Nations Environment Programme (UNEP), municipal solid waste generation is projected to exceed 3.8 billion tonnes globally by 2050, increasing the need for efficient recycling systems and secondary raw material utilization. Additionally, the European Environment Agency (EEA) highlights that recycled glass significantly reduces energy consumption and carbon emissions in glass manufacturing, as cullet melts at lower temperatures compared to virgin raw materials.

Rapeseed oil market is projected to grow from $30.3 billion in 2026 to $47.7 billion by 2035, expanding at a CAGR of 4.7% during the forecast period. The market growth is primarily driven by rising consumer demand for healthier edible oils, increasing applications in biodiesel production, and expanding use across food processing, cosmetics, and industrial sectors. A key macro driver influencing the market is the growing global demand for plant-based and heart-healthy cooking oils. According to the Food and Agriculture Organization (FAO), global vegetable oil consumption continues to rise due to population growth, urbanisation, and changing dietary preferences toward healthier fats with lower saturated fat content. Rapeseed oil, particularly low erucic acid canola-type oil, is widely recognised for its favourable omega-3 and omega-6 fatty acid profile, making it increasingly preferred in household cooking, processed foods, and foodservice applications. Additionally, sustainability initiatives and renewable fuel policies are accelerating the use of rapeseed oil in biodiesel production.